ATJ-16699-45822
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 774 / TX
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Moderna
-
2021-03-14
Registered in v-safe
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-18
- 2021-03-21
-
2021-04-20
Dose 2 — Moderna
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-13
- 2021-07-20
- 2021-10-21
-
2022-04-20
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID!MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Moderna | |
| 2 | 2021-04-20 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 11 — 12 months, dose 2
Symptoms: COVID!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release